Delta sleep-inducing peptide has been examined in small sleep and daytime-performance studies.
DSIP stands for delta sleep-inducing peptide. Researchers have investigated DSIP in small sleep studies; its name does not establish that a supplied vial induces sleep or improves sleep quality.
The named research compound is described here; the identity and formulation of this catalogue vial have not been independently verified.
Reviewed 2026-10-26
Human — small placebo-controlled study
14 middle-aged people with chronic insomnia.
A double-blind study reported changes in sleep and daytime performance after short-term DSIP administration.
A small, older study with short observation cannot establish dependable efficacy or long-term safety. Safety details are limited in the abstract.
PMID 3622582. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Compound name and formula checked via PubChem PUG REST. This reference does not verify the vial, salt or formulation.
PubChemMechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.
DrugBankProtein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.
UniProtBioactivity search. Assay results depend on the tested compound, target and experimental conditions.
ChEMBLExplore indexed literature. Search results are not supporting citations; selected verified publications appear above.
PubMedExplore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.
ClinicalTrials.govEvidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
DSIP stands for delta sleep-inducing peptide. Researchers have investigated DSIP in small sleep studies; its name does not establish that a supplied vial induces sleep or improves sleep quality.
The DSIP profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
DSIP and chronic insomnia (1987): Human — small placebo-controlled study
Publication: DSIP and chronic insomniaDSIP and chronic insomnia (1987): 14 middle-aged people with chronic insomnia.
Publication: DSIP and chronic insomniaThe named research compound is described here; the identity and formulation of this catalogue vial have not been independently verified.
DSIP and chronic insomnia (1987): A small, older study with short observation cannot establish dependable efficacy or long-term safety. Safety details are limited in the abstract.
Publication: DSIP and chronic insomniaThese studies do not establish the identity, purity, safety or effects of the MXC DSIP vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.